Back


08/11/2017
Horama raises €19 million in a Series B financing round
Horama raises 19 million euros from new investors (Kurma Partners, Fund+, Pontifax and Idinvest) and existing investors (Omnes Capital, GO Capital and Sham Innovation Santé/Turenne) to fund the development of gene therapy treatments for rare retinal diseases [...]

Download the pdf file





X

X